The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biosimulation-Global Market Insights and Sales Trends 2024
Synopsis
The global Biosimulation market size is expected to reach US$ 3686.5 million by 2029, growing at a CAGR of 12.7% from 2023 to 2029. The market is mainly driven by the significant applications of Biosimulation in various end use industries. The expanding demands from the Hospital, Scientific Research Institutions, Government Department and Other, are propelling Biosimulation market. Molecular Simulation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Clinical Trials segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Biosimulation market, driven by demand from China, the second largest economy with some signs of stabilising, the Biosimulation market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biosimulation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biosimulation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biosimulation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biosimulation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biosimulation covered in this report include Accelrys, Certara, Simulation Plus, Dassault Systems SA, Schrodinger, Advanced Chemistry Development, Chemical Computing Group, Entelos Holding Corporation and Genedata AG, etc.
The global Biosimulation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Accelrys
Certara
Simulation Plus
Dassault Systems SA
Schrodinger
Advanced Chemistry Development
Chemical Computing Group
Entelos Holding Corporation
Genedata AG
Physiomics PLC
Global Biosimulation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biosimulation market, Segment by Type:
Molecular Simulation
Clinical Trials
Toxicity Prediction Software
Other
Global Biosimulation market, by Application
Hospital
Scientific Research Institutions
Government Department
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biosimulation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Biosimulation market size is expected to reach US$ 3686.5 million by 2029, growing at a CAGR of 12.7% from 2023 to 2029. The market is mainly driven by the significant applications of Biosimulation in various end use industries. The expanding demands from the Hospital, Scientific Research Institutions, Government Department and Other, are propelling Biosimulation market. Molecular Simulation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Clinical Trials segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Biosimulation market, driven by demand from China, the second largest economy with some signs of stabilising, the Biosimulation market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biosimulation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biosimulation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biosimulation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biosimulation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biosimulation covered in this report include Accelrys, Certara, Simulation Plus, Dassault Systems SA, Schrodinger, Advanced Chemistry Development, Chemical Computing Group, Entelos Holding Corporation and Genedata AG, etc.
The global Biosimulation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Accelrys
Certara
Simulation Plus
Dassault Systems SA
Schrodinger
Advanced Chemistry Development
Chemical Computing Group
Entelos Holding Corporation
Genedata AG
Physiomics PLC
Global Biosimulation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biosimulation market, Segment by Type:
Molecular Simulation
Clinical Trials
Toxicity Prediction Software
Other
Global Biosimulation market, by Application
Hospital
Scientific Research Institutions
Government Department
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biosimulation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biosimulation
1.1 Biosimulation Market Overview
1.1.1 Biosimulation Product Scope
1.1.2 Biosimulation Market Status and Outlook
1.2 Global Biosimulation Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biosimulation Market Size by Region (2018-2029)
1.4 Global Biosimulation Historic Market Size by Region (2018-2023)
1.5 Global Biosimulation Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biosimulation Market Size (2018-2029)
1.6.1 North America Biosimulation Market Size (2018-2029)
1.6.2 Europe Biosimulation Market Size (2018-2029)
1.6.3 Asia-Pacific Biosimulation Market Size (2018-2029)
1.6.4 Latin America Biosimulation Market Size (2018-2029)
1.6.5 Middle East & Africa Biosimulation Market Size (2018-2029)
2 Biosimulation Market by Type
2.1 Introduction
2.1.1 Molecular Simulation
2.1.2 Clinical Trials
2.1.3 Toxicity Prediction Software
2.1.4 Other
2.2 Global Biosimulation Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biosimulation Historic Market Size by Type (2018-2023)
2.2.2 Global Biosimulation Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biosimulation Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biosimulation Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biosimulation Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biosimulation Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biosimulation Revenue Breakdown by Type (2018-2029)
3 Biosimulation Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Scientific Research Institutions
3.1.3 Government Department
3.1.4 Other
3.2 Global Biosimulation Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biosimulation Historic Market Size by Application (2018-2023)
3.2.2 Global Biosimulation Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biosimulation Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biosimulation Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biosimulation Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biosimulation Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biosimulation Revenue Breakdown by Application (2018-2029)
4 Biosimulation Competition Analysis by Players
4.1 Global Biosimulation Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimulation as of 2022)
4.3 Date of Key Players Enter into Biosimulation Market
4.4 Global Top Players Biosimulation Headquarters and Area Served
4.5 Key Players Biosimulation Product Solution and Service
4.6 Competitive Status
4.6.1 Biosimulation Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Accelrys
5.1.1 Accelrys Profile
5.1.2 Accelrys Main Business
5.1.3 Accelrys Biosimulation Products, Services and Solutions
5.1.4 Accelrys Biosimulation Revenue (US$ Million) & (2018-2023)
5.1.5 Accelrys Recent Developments
5.2 Certara
5.2.1 Certara Profile
5.2.2 Certara Main Business
5.2.3 Certara Biosimulation Products, Services and Solutions
5.2.4 Certara Biosimulation Revenue (US$ Million) & (2018-2023)
5.2.5 Certara Recent Developments
5.3 Simulation Plus
5.3.1 Simulation Plus Profile
5.3.2 Simulation Plus Main Business
5.3.3 Simulation Plus Biosimulation Products, Services and Solutions
5.3.4 Simulation Plus Biosimulation Revenue (US$ Million) & (2018-2023)
5.3.5 Dassault Systems SA Recent Developments
5.4 Dassault Systems SA
5.4.1 Dassault Systems SA Profile
5.4.2 Dassault Systems SA Main Business
5.4.3 Dassault Systems SA Biosimulation Products, Services and Solutions
5.4.4 Dassault Systems SA Biosimulation Revenue (US$ Million) & (2018-2023)
5.4.5 Dassault Systems SA Recent Developments
5.5 Schrodinger
5.5.1 Schrodinger Profile
5.5.2 Schrodinger Main Business
5.5.3 Schrodinger Biosimulation Products, Services and Solutions
5.5.4 Schrodinger Biosimulation Revenue (US$ Million) & (2018-2023)
5.5.5 Schrodinger Recent Developments
5.6 Advanced Chemistry Development
5.6.1 Advanced Chemistry Development Profile
5.6.2 Advanced Chemistry Development Main Business
5.6.3 Advanced Chemistry Development Biosimulation Products, Services and Solutions
5.6.4 Advanced Chemistry Development Biosimulation Revenue (US$ Million) & (2018-2023)
5.6.5 Advanced Chemistry Development Recent Developments
5.7 Chemical Computing Group
5.7.1 Chemical Computing Group Profile
5.7.2 Chemical Computing Group Main Business
5.7.3 Chemical Computing Group Biosimulation Products, Services and Solutions
5.7.4 Chemical Computing Group Biosimulation Revenue (US$ Million) & (2018-2023)
5.7.5 Chemical Computing Group Recent Developments
5.8 Entelos Holding Corporation
5.8.1 Entelos Holding Corporation Profile
5.8.2 Entelos Holding Corporation Main Business
5.8.3 Entelos Holding Corporation Biosimulation Products, Services and Solutions
5.8.4 Entelos Holding Corporation Biosimulation Revenue (US$ Million) & (2018-2023)
5.8.5 Entelos Holding Corporation Recent Developments
5.9 Genedata AG
5.9.1 Genedata AG Profile
5.9.2 Genedata AG Main Business
5.9.3 Genedata AG Biosimulation Products, Services and Solutions
5.9.4 Genedata AG Biosimulation Revenue (US$ Million) & (2018-2023)
5.9.5 Genedata AG Recent Developments
5.10 Physiomics PLC
5.10.1 Physiomics PLC Profile
5.10.2 Physiomics PLC Main Business
5.10.3 Physiomics PLC Biosimulation Products, Services and Solutions
5.10.4 Physiomics PLC Biosimulation Revenue (US$ Million) & (2018-2023)
5.10.5 Physiomics PLC Recent Developments
6 North America
6.1 North America Biosimulation Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Biosimulation Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biosimulation Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biosimulation Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biosimulation Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biosimulation Market Dynamics
11.1 Biosimulation Industry Trends
11.2 Biosimulation Market Drivers
11.3 Biosimulation Market Challenges
11.4 Biosimulation Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
